Cancer prevention by tocopherols and tea polyphenols

Cancer Letters

Volumn 334, Issue 1, 2013, Pages 79-85

  Yang, Chung S ^a   Li, Guangxun ^a   Yang, Zhihong ^a   Guan, Fei ^a   Chen, Amber ^a   Ju, Jihyeung ^b  

^a RUTGERS UNIVERSITY   (United States)

^b Chungbuk National University   (South Korea)

Author keywords

Cancer prevention; Green tea; Polyphenols; Tocopherols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ATORVASTATIN; BETA TOCOPHEROL; CAFFEINE; DELTA TOCOPHEROL; EPIGALLOCATECHIN GALLATE; GAMMA TOCOPHEROL; POLYPHENOL DERIVATIVE; POLYPHENON E; TOCOPHEROL DERIVATIVE; ANTINEOPLASTIC AGENT; POLYPHENOL; TEA; TOCOPHEROL;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; COLON CANCER; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ESOPHAGUS CANCER; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; STOMACH CANCER; TEA; ANIMAL; CHEMISTRY; COLONIC NEOPLASMS; DISEASE MODEL; LUNG NEOPLASMS; MALE; MOUSE; PROSTATIC NEOPLASMS;

ANIMALIA;

ANIMALS; ANTICARCINOGENIC AGENTS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; MALE; MICE; POLYPHENOLS; PROSTATIC NEOPLASMS; TEA; TOCOPHEROLS; VITAMIN E;

EID: 84891929814     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.051     Document Type: Review

References (58)

1. Traber M.G. Vitamin E. Present Knowledge in Nutrition 2006, 211-219. ILSI Press, Washington DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
2. Patel A., Liebner F., Netscher T., Mereiter K., Rosenau T. Vitamin E chemistry. Nitration of non-alpha-tocopherols: products and mechanistic considerations. J. Org. Chem. 2007, 72:6504-6512.
3. Ju J., Picinich S.C., Yang Z., Zhao Y., Suh N., Kong A.N., Yang C.S. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010, 31:533-542.
4. Mahabir S., Schendel K., Dong Y.Q., Barrers S.L., Spitz M.R., Forman M.R. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int. J. Cancer 2008, 123:1173-1180.
5. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294:56-65.
6. Gaziano J.M., Glynn R.J., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Sesso H.D., Buring J.E. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009, 301:52-62.
7. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D., Crawford E.D., Goodman G.E., Claudio J., Winquist E., Cook E.D., Karp D.D., Walther P., Lieber M.M., Kristal A.R., Darke A.K., Arnold K.B., Ganz P.A., Santella R.M., Albanes D., Taylor P.R., Probstfield J.L., Jagpal T.J., Crowley J.J., Meyskens F.L., Baker L.H., Coltman C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
8. Klein E.A., Thompson I.M., Tangen C.M., Crowley J.J., Lucia M.S., Goodman P.J., Minasian L.M., Ford L.G., Parnes H.L., Gaziano J.M., Karp D.D., Lieber M.M., Walther P.J., Klotz L., Parsons J.K., Chin J.L., Darke A.K., Lippman S.M., Goodman G.E., Meyskens F.L., Baker L.H. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011, 306:1549-1556.
9. Wagner K.H., Kamal-Eldin A., Elmadfa I. Gamma-tocopherol - an underestimated vitamin?. Ann. Nutr. Metab. 2004, 48:169-188.
10. Jiang Q., Christen S., Shigenaga M.K., Ames B.N. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 2001, 74:714-722.
11. Campbell S., Stone W., Whaley S., Krishnan K. Development of gamma-tocopherol as a colorectal cancer chemopreventive agent. Crit. Rev. Oncol. Hematol. 2003, 47:249-259.
12. Hensley K., Benaksas E.J., Bolli R., Comp P., Grammas P., Hamdheydari L., Mou S., Pye Q.N., Stoddard M.F., Wallis G., Williamson K.S., West M., Wechter W.J., Floyd R.A. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radical Biol. Med. 2004, 36:1-15.
13. Reiter E., Jiang Q., Christen S. Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol. Aspects Med. 2007, 28:668-691.
14. Lu G., Xiao H., Li G., Chen K.-Y., Hao J., Loy S., Yang C.S. γ-tocopherols-rich mixture of tocopherols inhibits chemically-induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis 2010, 31:687-694.
15. Li G.X., Lee M.J., Liu A.B., Yang Z., Lin Y., Shih W.J., Yang C.S. Delta-tocopherol is more active than alpha - or gamma -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prevent. Res. (Phila) 2011, 4:404-413.
16. Lambert J.D., Lu G., Lee M.J., Hu J., Yang C.S. Inhibition of lung cancer growth in mice by dietary mixed tocopherols. Mol. Nutr. Food Res. 2009, 53:1030-1035.
17. Ju J., Hao X., Lee M.J., Lambert J.D., Lu G., Xiao H., Newmark H.L., Yang C.S. A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prevent. Res. (Phila Pa) 2009, 2:143-152.
18. Lee H.J., Ju J., Paul S., So J.Y., DeCastro A., Smolarek A.K., Lee M.J., Yang C.S., Newmark H.L., Suh N. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-g. Clin. Cancer Res. 2009, 15:4242-4249.
19. Suh N., Paul S., Lee H.J., Ji Y., Lee M.J., Yang C.S., Reddy B.S., Newmark H.L. Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats. Nutr. Cancer 2007, 59:76-81.
20. Zheng X., Cui X.-X., Khor T.O., Huang Y., DiPaola R.S., Goodin S., Lee M.-J., Yang C.S., Kong A.-N., H C.A. Inhibitory effect of a γ-tocopherol-rich mixture of tocopherols on the formation and growth of LNCaP prostate tumors in immunodeficient mice. Cancers 2012, 3:3762-3772.
21. Barve A., Khor T.O., Nair S., Reuhl K., Suh N., Reddy B., Newmark H., Kong A.N. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int. J. Cancer 2009, 124:1693-1699.
22. Guan F., Li G.X., Liu A.B., Lee M.-J., Yang Z., Chen Y.-K., Lin Y., Shih W., Yang C.S. Delta- and gramma-tocopherols, but no alpha-tocopherols, inhibit colon carcinogenesis in azoxymethane-treated F344 rats. Cancer Prevent. Res. 2012, 5:644-654.
23. Yang C.S., Suh N., Kong A.N. Does vitamin E prevent or promote cancer?. Cancer Prevent. Res. 2012, 5:701-705.
24. Smolarek A.K., Suh N. Chemopreventive activity of vitamin E in breast cancer: a focus on gamma- and delta-tocopherol. Nutrients 2011, 3:962-986.
25. Takahashi S., Takeshita K., Seeni A., Sugiura S., Tang M., Sato S.Y., Kuriyama H., Nakadate M., A.K., Maeno Y., Nagao M., Shirai T. Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Display Settings 2009, 69:644-651.
26. Helzlsouer K.J., Huang H.Y., Alberg A.J., Hoffman S., Burke A., Norkus E.P., Morris J.S., Comstock G.W. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J. Natl. Cancer Inst. 2000, 92:2018-2023.
27. Huang H.Y., Alberg A.J., Norkus E.P., Hoffman S.C., Comstock G.W., Helzlsouer K.J. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 2003, 157:335-344.
28. Yang C.S., Wang Z.Y. Tea and cancer. J. Natl. Cancer Inst. 1993, 85:1038-1049.
29. Sang S., Lambert J.D., Ho C.T., Yang C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res. 2011, 64:87-99.
30. Yang C.S., Sang S., Lambert J.D., Lee M.J. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol. Nutr. Food Res. 2008, 52(Suppl. 1):S139-151.
31. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9:429-439.
32. Ermakova S., Choi B.Y., Choi H.S., Kang B.S., Bode A.M., Dong Z. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 2005, 280:16882-16890.
33. Tachibana H., Koga K., Fujimura Y., Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 2004, 11:380-381.
34. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003, 63:8118-8121.
35. Urusova D.V., Shim J.H., Kim D.J., Jung S.K., Zykova T.A., Carper A., Bode A.M., Dong Z. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prevent. Res. (Phila) 2011, 4:1366-1377.
36. Ju J., Lu G., Lambert J.D., Yang C.S. Inhibition of carcinogenesis by tea constituents. Semin. Cancer Biol. 2007, 17:395-402.
37. Chung F.L., Wang M., Rivenson A., Iatropoulos M.J., Reinhardt J.C., Pittman B., Ho C.T., Amin S.G. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res. 1998, 58:4096-4101.
38. Wang Z.Y., Hong J.Y., Huang M.T., Reuhl K.R., Conney A.H., Yang C.S. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 1992, 52:1943-1947.
39. Lu G., Liao J., Yang G., Reuhl K.R., Hao X., Yang C.S. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006, 66:11494-11501.
40. Lu G., Xiao H., You H., Lin Y., Jin H., Snagaski B., Yang C.S. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin. Cancer Res. 2008, 14:4981-4988.
41. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., Yang G.Y., Liu Y.Y., Hou Z., Lin Y., Ma J., Shih W.J., Carothers A.M., Yang C.S. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005, 65:10623-10631.
42. Ju J., Liu Y., Hong J., Huang M.T., Conney A.H., Yang C.S. Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr. Cancer 2003, 46:172-178.
43. Shimizu M., Shirakami Y., Sakai H., Adachi S., Hata K., Hirose Y., Tsurumi H., Tanaka T., Moriwaki H. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prevent. Res. (Phila) 2008, 1:298-304.
44. Xiao H., Hao X., Simi B., Ju J., Jiang H., Reddy B.S., Yang C.S. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 2008, 29:113-119.
45. Gupta S., Hastak K., Ahmad N., Lewin J.S., Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad Sci. USA 2001, 98:10350-10355.
46. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004, 64:8715-8722.
47. Caporali A., Davalli P., Astancolle S., D'Arca D., Brausi M., Bettuzzi S., Corti A. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 2004, 25:2217-2224.
48. Lubet R.A., Yang C.S., Lee M.J., Hara Y., Kapetanovic I.M., Crowell J.A., Steele V.E., Juliana M.M., Grubbs C.J. Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols. Mol. Cancer Ther. 2007, 6:2022-2028.
49. Rogers A.E., Hafer L.J., Iskander Y.S., Yang S. Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis 1998, 19:1269-1273.
50. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int. J. Urol. 1999, 6:93-99.
51. Sato D., Matsushima M. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int. J. Urol. 2003, 10:160-166.
52. Conney A.H., Zhou S., Lee M.J., Xie J.G., Yang C.S., Lou Y.R., Lu Y. Stimulatory effect of oral administration of tea, coffee or caffeine on UVB-induced apoptosis in the epidermis of SKH-1 mice. Toxicol. Appl. Pharmacol. 2007, 224:209-213.
53. Hong J., Lu H., Meng X., Ryu J.H., Hara Y., Yang C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002, 62:7241-7246.
54. Schwartz J.L., Baker V., Larios E., Chung F.L. Molecular and cellular effects of green tea on oral cells of smokers: a pilot study. Mol. Nutr. Food Res. 2005, 49:43-51.
55. Hakim I.A., Harris R.B., Brown S., Chow H.H., Wiseman S., Agarwal S., Talbot W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 2003, 133:3303S-3309S.
56. Yuan J.M., Sun C., Butler L.M. Tea and cancer prevention: epidemiological studies. Pharmacol. Res. 2011, 64:123-135.
57. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Dai Q., Fraumeni J.F. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 1994, 86:855-858.
58. Sasazuki S., Tamakoshi A., Matsuo K., Ito H., Wakai K., Nagata C., Mizoue T., Tanaka K., Tsuji I., Inoue M., Tsugane S. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 2012, 42:335-346.